Impact des réglementations sur la recherche de transfert en thérapie génique et cellulaire : l'exemple américain = Impact of regulations on translational research in cell and gene therapy: the US experienceROUSSEAU, Raphaël F; GEE, Adrian P.Bulletin du cancer. 2004, Vol 91, Num 3, pp 239-247, issn 0007-4551, 9 p.Article

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipientsSAVOLDO, Barbara; GOSS, John; ZHENSHENG LIU et al.Transplantation. 2001, Vol 72, Num 6, pp 1078-1086, issn 0041-1337Article

Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function: The LateTIME Randomized TrialTRAVERSE, Jay H; HENRY, Timothy D; PERIN, Emerson C et al.JAMA, the journal of the American Medical Association. 2011, Vol 306, Num 19, pp 2110-2119, issn 0098-7484, 10 p.Article

Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infectionLEE, Timothy C; GOSS, John A; ROONEY, Cliona M et al.Clinical transplantation. 2006, Vol 20, Num 6, pp 689-694, issn 0902-0063, 6 p.Article

Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleZIEROLD, Claudia; CARLSON, Marjorie A; ELLIS, Stephen G et al.The American heart journal. 2011, Vol 162, Num 6, pp 973-980, issn 0002-8703, 8 p.Article

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarctionTRAVERSE, Jay H; HENRY, Timothy D; PERIN, Emerson C et al.The American heart journal. 2009, Vol 158, Num 3, pp 356-363, issn 0002-8703, 8 p.Article

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferBOLLARD, Catherine M; GOTTSCHALK, Stephen; GRESIK, M. Victoria et al.Blood. 2007, Vol 110, Num 8, pp 2838-2845, issn 0006-4971, 8 p.Article

Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studyRICHMAN, Sara; GEE, Adrian P; ZHAO, David et al.Transfusion (Philadelphia, PA). 2012, Vol 52, Num 10, pp 2225-2233, issn 0041-1132, 9 p.Article

Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction: The TIME Randomized TrialTRAVERSE, Jay H; HENRY, Timothy D; PERIN, Emerson C et al.JAMA, the journal of the American Medical Association. 2012, Vol 308, Num 22, pp 2380-2389, issn 0098-7484, 10 p.Article

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesHANLEY, Patrick J; YOUNG CRUZ, Conrad Russell; ROONEY, Cliona M et al.Blood. 2009, Vol 114, Num 9, pp 1958-1967, issn 0006-4971, 10 p.Article

Production Assistance for Cellular Therapies (PACT) : five-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapiesREED, William; NOGA, Stephen J; LINDBLAD, Robert W et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 4, pp 786-796, issn 0041-1132, 11 p.Article

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantationROUSSEAU, Raphael F; BIAGI, Ettore; GEE, Adrian P et al.Blood. 2006, Vol 107, Num 4, pp 1332-1341, issn 0006-4971, 10 p.Article

Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). CommentaryAMBINDER, Richard F; SAVOLDO, Barbara; SCHUBERT, Stephan et al.Blood. 2006, Vol 108, Num 9, issn 0006-4971, 2891,2942-2949 [9 p.]Article

HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancerSONPAVDE, Guru; MINGJUN WANG; WANG, Rong-Fu et al.Investigational new drugs. 2014, Vol 32, Num 2, pp 235-242, issn 0167-6997, 8 p.Article

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane ProteinsBOLLARD, Catherine M; GOTTSCHALK, Stephen; PRO, Barbara et al.Journal of clinical oncology. 2014, Vol 32, Num 8, pp 798-808, issn 0732-183X, 11 p.Article

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure: The FOCUS-CCTRN TrialPERIN, Emerson C; WILLERSON, James T; MARTIN, A. Daniel et al.JAMA, the journal of the American Medical Association. 2012, Vol 307, Num 16, pp 1717-1726, issn 0098-7484, 10 p.Article

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationLEEN, Ann M; CHRISTIN, Anne; BRENNER, Malcolm K et al.Blood. 2009, Vol 114, Num 19, pp 4283-4292, issn 0006-4971, 10 p.Article

Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsLOUIS, Chrystal U; STRAATHOF, Karin; ROONEY, Cliona M et al.Blood. 2009, Vol 113, Num 11, pp 2442-2450, issn 0006-4971, 9 p.Article

Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipientsLEE, Timothy C; SAVOLDO, Barbara; BARSHES, Neal R et al.Clinical transplantation. 2006, Vol 20, Num 3, pp 389-393, issn 0902-0063, 5 p.Article

Inducible Apoptosis as a Safety Switch for Adoptive Cell TherapyDI STASI, Antonio; TEY, Siok-Keen; HAO LIU et al.The New England journal of medicine. 2011, Vol 365, Num 18, pp 1673-1683, issn 0028-4793, 11 p.Article

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaLOUIS, Chrystal U; SAVOLDO, Barbara; HAO LIU et al.Blood. 2011, Vol 118, Num 23, pp 6050-6056, issn 0006-4971, 7 p.Article

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationMICKLETHWAITE, Kenneth P; SAVOLDO, Barbara; HESLOP, Helen E et al.Blood. 2010, Vol 115, Num 13, pp 2695-2703, issn 0006-4971, 9 p.Article

Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and ImmunotherapyLEEN, Ann M; CHRISTIN, Anne; KHALIL, Mariam et al.Journal of virology. 2008, Vol 82, Num 1, pp 546-554, issn 0022-538X, 9 p.Article

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipientsLEE, Timothy C; SAVOLDO, Barbara; GOSS, John A et al.American journal of transplantation (Print). 2005, Vol 5, Num 9, pp 2222-2228, issn 1600-6135, 7 p.Article

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytesSTRAATHOF, Karin C. M; BOLLARD, Catherine M; ROONEY, Cliona M et al.Blood. 2005, Vol 105, Num 5, pp 1898-1904, issn 0006-4971, 7 p.Article